Elizabeth Phillips Archive — Page 2 of 3

Silver medical-alert necklace with a tag labeled “PENICILLIN ALLERGY” and “SEE WALLET CARD,” alongside a medical emblem.
September 29, 2022

Penicillin delabeling initiative expanding to more patient care areas

Efforts to correct mistaken or outdated penicillin allergy records are destined to spread to more patient care areas at Vanderbilt University Medical Center.

Several syringes with orange safety caps arranged beside medical packaging and a partially visible label reading “COVID-19 Vaccine.”
January 24, 2022

Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines

Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children.

Conceptual 3D illustration of red, spiked SARS-CoV-2 particles surrounded by Y-shaped ACE2 receptors on a glowing orange background.
August 12, 2021

Certain drug exposures correlate with reduced COVID severity: study

Analyzing electronic health records (EHR) of 9,748 patients diagnosed with COVID-19, Cosmin Bejan, PhD, Elizabeth Phillips, MD, and colleagues at Vanderbilt University Medical Center asked whether COVID disease severity correlated with any drugs that happened to be taken by these patients in the months leading up to their diagnosis.

Professional head-and-shoulders portrait of Elizabeth Phillips, MD, wearing a gray blazer and pearl necklace against a softly blurred brown backdrop.
July 27, 2021

Using Patients’ Allergy History as Screening Tool for mRNA COVID-19 Vaccine Works Well: Study

A report of more than 23,000 health care workers and employees at Vanderbilt University Medical Center who received the Pfizer-BioNTech mRNA COVID-19 vaccine shows that a risk stratification screening mechanism for potential allergies to the vaccine worked exceedingly well as the vaccine program rolled out in December 2020.

Close-up stylized graphic displaying the words “COVID-19” and “VIRUS” over a dark digital interface with glowing lines, numbers, and circuit-like patterns.
March 18, 2021

Study to assess allergic reactions to COVID vaccines

Vanderbilt University Medical Center is recruiting volunteers for a randomized controlled phase 2 clinical trial to help determine the prevalence of systemic allergic reactions (SARS) to the two-dose COVID-19 mRNA vaccines made by Pfizer-BioNTech and Moderna.

Silver medical-alert necklace with a tag labeled “PENICILLIN ALLERGY” and “SEE WALLET CARD,” alongside a medical emblem.
October 1, 2020

Genes spell penicillin allergy risk

Studies using large DNA biobanks revealed genetic variants associated with penicillin allergy, the most common type of drug-induced allergic reaction.